BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30341520)

  • 1. MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.
    Zhou DN; Li SJ; Ding JL; Yin TL; Yang J; Ye H
    Curr Med Sci; 2018 Oct; 38(5):853-860. PubMed ID: 30341520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
    He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
    Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rat Model of Polycystic Ovary Syndrome with Insulin Resistance Induced by Letrozole Combined with High Fat Diet.
    Wang MX; Yin Q; Xu X
    Med Sci Monit; 2020 May; 26():e922136. PubMed ID: 32448863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats.
    He Z; Wang Y; Zhuan L; Li Y; Tang ZO; Wu Z; Ma Y
    Cytokine; 2021 Oct; 146():155632. PubMed ID: 34242901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome.
    Calan M; Kume T; Yilmaz O; Arkan T; Kocabas GU; Dokuzlar O; Aygün K; Oktan MA; Danıs N; Temur M
    Endocr Res; 2016 Aug; 41(3):261-9. PubMed ID: 26913980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of Kuntai Capsules in treatment of polycystic ovary syndrome rat models based on AGE-RAGE signal pathway].
    Huang JG; Zhang J; Xiang RJ; Wu YY; He TY; Zhao MN; Wang F
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1082-1090. PubMed ID: 38621915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
    Shen HR; Xu X; Li XL
    Reprod Biol Endocrinol; 2021 Jan; 19(1):3. PubMed ID: 33407557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
    Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
    Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
    Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
    Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total flavonoids extracted from
    Zhou Y; Lv L; Liu Q; Song J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30463907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Acupuncture on Reproductive Endocrine and p-Akt Protein Expression in Polycystic Ovary Syndrome Rats with Insulin Resistance].
    Zhang Y; Cao S; Wen SD; Re ZC; Li YP; Tong L
    Zhen Ci Yan Jiu; 2018 Oct; 43(10):622-6. PubMed ID: 30365256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of berberine on LPS /NF-κB and MAPK signaling pathways in PCOS model rats].
    Zhao FQ; Zhao Y; Liu JY; Gou YJ; Yang YQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):181-186. PubMed ID: 36031579
    [No Abstract]   [Full Text] [Related]  

  • 17. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats.
    Patel R; Shah G
    Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent therapeutic effects of shouwu jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats.
    Wang LH; Wang X; Yu XZ; Xu WT
    Chin J Integr Med; 2016 Feb; 22(2):116-23. PubMed ID: 26179926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
    Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
    Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.